Brief Summary of the Proposed Expansion Project

Agenda Item No. 17.7.8 in 17th REAC meeting, File No.J-11011/25/2014-IA-II(I) Title of the Project Proposed Expansion of Bulk Drugs and its Intermediates Manufacturing unit (300TPA) at Sy. Nos. 21/A & 21 AA, Mambapur(V), Jinnaram(M), Medak district, A.P by M/s. MSN Life Sciences Pvt. Ltd., (formerly known as M/s. Vijeta Life Sciences Pvt. Ltd.,) Category of Project A Project Proponent Dr. M.S.N. Reddy, Managing Director M/s. Vijeta Life Sciences Pvt. Ltd., Hyderabad. Land acquired 1.08 Ha (10863Sq.m); Existing- 0.7790 Ha and additional- 0.3073 Ha Land in possession of Project Proponent. Cost of the Rs. 22 crores (including Rs. 7 crores existing investment) expansion Project Cost towards Capital :Rs. 3.0 crores environmental Recurring Cost : Rs.1.9 crores per annum Protection measures Proposed facilities 1. Production Blocks, Raw materials / finished products stores, Utilities, Q.C & Q.A, Solvent storage area, Solvent recovery system, Effluent Treatment Plant with Zero Liquid Discharge, Administration Block, Canteen, Training block etc. 2. Laying of black top / concrete internal roads. 3. Fire hydrant facility 4. First Aid kits at all prominent places. Production capacity Proposed products and their capacities on campaign basis –5 out of 24 products at a time (300TPA). S.N Quantity Therapeutic Product Name o. (TPA) Category 1. Voriconazole 36 Antifungal 2. Posaconazole 6 Antifungal 3. Dronedarone Hydrochloride 6 Antiarrhythmic 4. Clopidogrel Bisulfate 48 Antiplatelet drug 5. Olopatadine Hydrochloride 144 Antiallergic agent Treatment of 6. Silodosin 1.08 Benign Prostatic Hyperplasia 7. DabigatranEtexilateMesylate 3 Anticoagulant 8. Rosuvastatin Calcium 12 Antilipemic Analgesic & 9. Pregabalin 24 Antipyretic 10. Saxagliptin Monohydrate 1.08 Antidiabetic 11. Darunavir 3 Antiretroviral 12. Telaprevir 2.04 Antiviral 13. Boceprevir 3 Antiviral 14. Ranolazine 48 Antianginals

15. Satigrel 9 Antithrombotic 16. Fasudil Hydrochloride 9 Vasodilator 17. Ramatroban 9 Antiasthmatic 18. Talampanel 9 Antiepileptic

19. Ramipril 9 Antihypertensive 20. Tiagabine Hydrochloride 6 Anticonvulsant 21. BifeprunoxMesylate 9 Antipsychotic 22. Cangrelor 2.4 Antithrombotic 23. Cilomilast 2.4 Antiasthmatic 24. Argatroban 6 Antithrombotic Maximum Production Capacity on 300 various combinations

(i.e. any 5 Products at a point of time) Proposed air Process Emissions: HCl, SO2, NH3, CO2, n-Butane, O2 and H2emissions are pollution control liberated from the process. HCl, NH3 and SO2 emissions will be scrubbed with measures water/caustic and the scrubbing liquid sent for further treatment. CO2, and O2 emissions will be dispersed into atmosphere. H2 and N-Butane will be diffused with flame arrestor. Boiler emissions: Multicyclone separator and bag filter with a stack height of 30m will be installed for controlling the Particulate emissions from the proposed boilers of 3TPH & existing 1TPH Boiler. Water Existing -13.6 KLD Requirement Proposed-136.9KLD (Fresh water requirement is 91.9 KLD and Balance 45 KLD reused after treatment) Wastewater Effluent Type Treatment Flow treatment Process & Scrubber Collection Equalization  Neutralization  Qty.: 18.4 KLD Settling  Holding tank  Steam stripper  MEE along with Scrubber effluent  Condensate to ETP HTDS > 5000 mg/l  Concentrate to ATFD. HCOD > 5000 mg/l Salts to TSDF. Collection Equalization  Neutralization  Utilities & Settling  Holding tank  ETP (biological LTDS/LCOD treatment) along with Domestic (overflow from septic Qty.: 24 KLD tank) Dual Sand filter  Activated carbon filter  R.O. system Permeate to Utilities. LTDS < 5000 mg/l R.O rejects Forced evaporation condensate to LCOD < 5000 mg/ utilities. Salts to TSDF. Domestic Septic tank  overflow sent to ETP along with LTDS Qty.: 4 KLD / LCOD Effluent

Recycle & Reuse Zero Liquid Discharge: Treated effluent will be reused in Cooling Towers. Domestic wastewater sent to Biological Treatment of ETP for reuse in Cooling Towers Solid / Hazardous waste management Proposed Sl. Handling and disposal Source Quantity Disposal No. Method (TPD) 1. Organic residue 0.84 2. Spent Carbon 0.09 HDPE Sent to APPCB Drums Authorized Cement Distillation 3. 0.1 industries / TSDF Bottom Residue Inorganic & 0.9 4. Evaporation salt HDPE (Process) Bags Evaporation salt 5. 0.2 (Non-Process)

6. ETP Sludge 0.1 Stored in Sold to Cement Brick 7. Boiler Ash 8.5 covered Manufacturers area Other Hazardous Waste generation from the Plant

a) Detoxified Container / Disposed to APPCB 300 Designated Liners drums Authorized agencies 8. (Nos./month) covered b) HDPE Carboys after complete area c) Fiber Drums detoxification d) PP Bags Recovery within the Stored in premises duly sending 9. Spent solvents 11.5 KLD Drums / the residue to APPCB Tanks Authorized agencies Recovery within the Stored in Spent Mixed premises / Sent to 10. 1 KLD Drums / solvents APPCB Authorized Tanks agencies Sent to APPCB Waste oils & Stored in Authorized agencies 11. 1.5 KL/year Grease Drums for reprocessing / recycling. Designated Used Lead acid 20 Sent to suppliers on 12. covered Batteries Nos./year buy-back basis. area Misc. Waste Stored in 13. Lumpsum TSDF (spill control Drums

waste) Greenbelt 0.36 Ha (3600Sq. m)

iii